Group Meaning-Centered Psychotherapy for the Improvement of Wellbeing in Caregivers of Patients With Serious Illness

March 27, 2026 updated by: Deirdre R. Pachman, Mayo Clinic

Group Meaning-Centered Psychotherapy for Caregivers of Patients With Serious Life-Limiting Illness

This clinical trial assesses the acceptability and feasibility of a virtual group Meaning-Centered Psychotherapy for Cancer Caregivers (MCP-C) and its effect in improving the wellbeing of caregivers of patients with advanced cancer or a serious life-limiting illness. Caregivers often suffer from significant existential distress, which includes feelings of hopelessness, demoralization, burden, loss of meaning and dignity, and a decreased will to live. MCP-C seeks to help caregivers connect to meaning and purpose despite the challenges of caregiving and helps caregivers understand how sources of meaning may help with symptoms of burden and reduce despair. Participating in MCP-C may help improve sense of personal meaning, spiritual well-being, and mood in caregivers of patients with advanced cancer or a serious life-limiting illness.

Study Overview

Detailed Description

PRIMARY OBJECTIVES:

I. Determine feasibility as measured by total number of caregivers enrolled in 2 years (modification to extend study another year), adherence (75% of the enrolled participants will complete at least 6 of the 8 MCP groups).

II. Determine acceptability as measured by satisfaction with the research process, as measured by the Was It Worth It (WiWi 2.0) questionnaire.

III. To evaluate preliminary efficacy of group MCP-C for personal meaning as measured by Life Attitude Profile-Revised (LAP-R), spiritual wellbeing as measured by Functional Assessment of Chronic Illness Therapy (FACIT) Spiritual Well-Being Scale (SWBS), depression and anxiety symptoms as measured by Hospital Anxiety and Depression Scale (HADS), meaning in caregiving as measured by Attitudes Towards Caregiving Scale (ATCS), social support as measured by Duke-University of North Carolina (UNC) Functional Social Support Questionnaire (FSSQ), benefit finding as measured by Benefit Finding Scale (BFS).

IV. Determine participants' perceptions of their experience with the intervention, including potential benefits they experienced, which components had the greatest impact, and whether they would suggest any changes to the intervention.

OUTLINE:

Caregivers participate in MCP-C virtual group discussion sessions over 90 minutes each and complete reading exercises and workbook assignments once weekly for 8 weeks throughout the study.

After completion of study intervention, caregivers are followed up at 2 months.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Jacksonville, Florida, United States, 32224-9980
        • Mayo Clinic in Florida
    • Minnesota
      • Rochester, Minnesota, United States, 55905
        • Mayo Clinic in Rochester

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age >= 18 years
  • English fluency
  • No diagnosed severe cognitive impairment
  • Caregiver of a patient with a diagnosis of advanced, solid tumor cancer (stage III/stage IV), caregivers supporting a patient with a serious life-limiting illness
  • Provide written (paper or electronic) informed consent
  • Ability to complete questionnaire(s) by themselves or with assistance
  • Patient baseline distress score >= 4/10
  • Have ability to utilize the technology to participate in virtual groups

Exclusion Criteria:

  • As determined through self-report, those diagnosed with a history of a psychotic episode will be excluded
  • Other psychological co-morbidities such as untreated schizophrenia, bipolar disease
  • Cognitive impairment likely to interfere with participation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Supportive Care (MCP-C)
Caregivers participate in MCP-C virtual group discussion sessions over 90 minutes each and complete reading exercises and workbook assignments once weekly for 8 weeks throughout the study.
Ancillary studies
Ancillary studies
Participate in MCP-C
Other Names:
  • Behavior Counseling
  • Behavioral Psychotherapy
Participate in virtual group discussions
Other Names:
  • Discuss
Receive reading exercises and workbook materials

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of Meaning-Centered Psychotherapy for Caregivers (MCP-C) intervention
Time Frame: Up to 1 year
Feasibility will be measured by numbers and percentages of participant recruitment, enrollment, accrual, and retention of participants in the MCP-C intervention. Findings will be summarized using estimates and corresponding 95% confidence intervals.
Up to 1 year
Acceptability of MCP-C intervention
Time Frame: 4 months (2 months post intervention)
Acceptability will be measured by the Was It Worth It (WIWI) Questionnaire. The WIWI consists of 7 questions, 3 answered with yes/no/uncertain, two answered on a 3-point scale (i.e., improved, stayed the same, or got worse), one open-ended/fill-in-the-blank question, and one yes/no question.
4 months (2 months post intervention)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in personal meaning - LAP-R
Time Frame: Baseline, 8 weeks (post intervention), 4 months (2 months post intervention)
The Life Attitude Profile-Revised (LAP-R) is a 48-item scale that measures a person's life attitude and meaning in life. The LAP-R is scored on a 7-point Likert scale, with a minimum score of 30 and a maximum score of 210. A higher score indicates a greater sense of meaning in life and a more positive attitude towards life.
Baseline, 8 weeks (post intervention), 4 months (2 months post intervention)
Change in spiritual well-being - FACIT-Sp-12
Time Frame: Baseline, 8 weeks (post intervention), 4 months (2 months post intervention)
Spiritual well-being will be assessed using the Functional Assessment of Chronic Illness Therapy Spiritual Well-Being Scale (FACIT-Sp-12), a 12-item self-report measure with a total score range of 0-48, with higher scores indicating a greater level of spiritual well-being. items are answered on a scale of 0-4 where 0=Not at all, 1=A little bit, 2=Somewhat, 3=Quite a bit, and 4=Very much.
Baseline, 8 weeks (post intervention), 4 months (2 months post intervention)
Changes in anxiety and depression - HADS
Time Frame: Baseline, 8 weeks (post intervention), 4 months (2 months post intervention)
Change in anxiety and depression will be assessed using the Hospital Anxiety and Depression Scale (HADS). The HADS is a 14-item self-rated questionnaire with depression and anxiety subscales both ranging from 0 to 21, categorized as: normal 0-7, mild 8-10, moderate 11-14, and severe 15-21. Items are answered on a scale of 0-3 with varying responses for each question (e.g., very much/quite a lot/not very much/not at all or often/sometimes/not often/very seldom).
Baseline, 8 weeks (post intervention), 4 months (2 months post intervention)
Change in attitude toward caregiving - ATCS
Time Frame: Baseline, 8 weeks (post intervention), 4 months (2 months post intervention)
Change in attitude toward caregiving will be assessed using the Attitudes Towards Caregiving Scale ( ATCS), a 43-item 5-point Likert-type measure of ways caregivers find meaning through caregiving. The ATCS yields an overall (range 43-215) and three subscale [loss/powerlessness (range 19-96), provisional meaning (range 19-96), and ultimate meaning (range 5-25)] scores, with higher scores indicating higher overall meaning. Items are answered with one of 5 responses: strongly agree, agree, undecided, disagree, or strongly disagree.
Baseline, 8 weeks (post intervention), 4 months (2 months post intervention)
Change in perception of social support - Duke-UNC FSSQ
Time Frame: Baseline, 8 weeks (post intervention), 4 months (2 months post intervention)
Change in perception of social support will be assessed using the Duke/University of North Caroling (UNC) Functional Social Support Questionnaire (FSSQ), an 8-item measure of social support that generates a total score (range 0-44). Higher scores generally indicate a higher degree of satisfaction related to social support. Items are answered on a scale of 5-1 where 5=as much as I would like; 4=almost as much as I would like; 3=some, but would like more; 2=less than i would like, and 1=much less than I would like.
Baseline, 8 weeks (post intervention), 4 months (2 months post intervention)
Change in benefit-finding - BFS
Time Frame: Baseline, 8 weeks (post intervention), 4 months (2 months post intervention)
Change in perception of benefit will be assessed using the Benefit Finding Scale (BFS), a 17-item measure of perceived benefits adapted from Behr's Positive Contributions Scale for breast cancer, modified for caregiving. It yields a total score (range 17-85) with higher scores indicating greater benefit finding. Items are answered with one of 5 responses: not at all, a little bit, somewhat, quite a bit, or very much.
Baseline, 8 weeks (post intervention), 4 months (2 months post intervention)
Change in Cancer Support Source Caregiver-18+ score
Time Frame: Baseline, 8 weeks (post intervention), 4 months (2 months post intervention)
The Cancer Support Source-Caregiver (CSS-Caregiver) is an 18-item questionnaire used to assess demands of cancer caregiving. Participants rate items of concern on a scale of 0 (not at all) to 4 (very seriously). A higher score indicates an item is of greater concern. Higher overall scores indicate higher levels of stress.
Baseline, 8 weeks (post intervention), 4 months (2 months post intervention)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Deirdre R. Pachman, MD, Mayo Clinic in Rochester

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 12, 2024

Primary Completion (Estimated)

September 12, 2026

Study Completion (Estimated)

September 12, 2026

Study Registration Dates

First Submitted

September 16, 2024

First Submitted That Met QC Criteria

October 4, 2024

First Posted (Actual)

October 8, 2024

Study Record Updates

Last Update Posted (Actual)

April 1, 2026

Last Update Submitted That Met QC Criteria

March 27, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Advanced Malignant Solid Neoplasm

Clinical Trials on Questionnaire Administration

Subscribe